CIK 0001531177 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sight Sciences, Inc.
Sign in to watch- Ticker
- SGHT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800625749
- Phone
- (415) 889-0550
- Business address
- 4040 CAMPBELL AVE,, SUITE 100, MENLO PARK, CA, 94025
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $652,777
- in 5 filings, $653K under 10b5-1 plans
Net −$652,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Badawi Paul −$268K President and CEO sold <1% of stake
- Bauerlein Alison −$224K Chief Operating Officer sold 4% of stake
- Badawi David −$71K Chief Technology Officer sold <1% of stake
- Rodberg James −$64K Chief Financial Officer sold 3% of stake
- Taylor Brenton −$26K EVP, Operations & R&D sold 1% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-12 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise 10b5-1 | +710 | $1.96 | $1K | 259,740 |
| 2025-11-12 | HAYDEN JEREMY B. Chief Legal Officer | Sale 10b5-1 | −3,150 | $8.01 | $25K | 256,590 |
| 2025-11-12 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,440 | 0 | ||
| 2025-11-12 | HAYDEN JEREMY B. Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −710 | 0 | ||
| 2025-11-11 | Bauerlein Alison Chief Operating Officer | Grant or award | +23,006 | 620,526 | ||
| 2025-11-11 | Rodberg James Chief Financial Officer | Grant or award | +15,337 | 161,363 | ||
| 2025-10-06 | Taylor Brenton EVP, Operations & R&D | Sale | −591 | $3.37 | $2K | 185,249 |
| 2025-10-03 | Badawi David Chief Technology Officer | Sale | −6,033 | $3.27 | $20K | 1,864,992 |
| 2025-10-03 | HAYDEN JEREMY B. Chief Legal Officer | Sale | −9,731 | $3.27 | $32K | 256,590 |
| 2025-10-02 | Bauerlein Alison Chief Financial Officer | Sale | −19,948 | $3.30 | $66K | 597,520 |
| 2025-10-01 | Badawi Paul President and CEO | Sale | −24,441 | $3.34 | $82K | 5,962,502 |
| 2025-09-11 | Mazzacco Catherine Director | Gift | −37,492 | 41,015 | ||
| 2025-09-02 | Taylor Brenton EVP, Operations & R&D | Grant or award | +25,840 | 185,840 | ||
| 2025-07-17 | Badawi David Chief Technology Officer | Option exercise | +40,000 | $0.12 | $5K | 1,871,025 |
| 2025-07-17 | Badawi David Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2025-07-03 | HAYDEN JEREMY B. Chief Legal Officer | Sale | −9,160 | $4.17 | $38K | 266,321 |
| 2025-07-03 | Badawi David Chief Technology Officer | Sale | −5,679 | $4.17 | $24K | 1,831,025 |
| 2025-07-02 | Bauerlein Alison Chief Financial Officer | Sale | −19,260 | $4.10 | $79K | 617,468 |
| 2025-07-02 | Link Matthew Chief Commercial Officer | Sale | −4,889 | $4.10 | $20K | 832,293 |
| 2025-07-01 | Badawi Paul President and CEO | Sale | −23,637 | $4.15 | $98K | 5,986,943 |
Page 4 of 7 · 126 trades